Home › Trial NCT04928573
Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab
- Trial IDNCT04928573
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorLibbs Farmacêutica LTDA
- Enrollment27
- Start date2022-02-08
- ConditionsDiffuse Large B Cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.